vs
Side-by-side financial comparison of BLACKLINE, INC. (BL) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
BLACKLINE, INC. is the larger business by last-quarter revenue ($183.2M vs $151.7M, roughly 1.2× Nutex Health, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs 2.7%, a 5.1% gap on every dollar of revenue. On growth, BLACKLINE, INC. posted the faster year-over-year revenue change (8.1% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $26.1M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 7.9%).
BlackLine Systems, Inc., is an American enterprise software company that develops cloud-based services designed to automate and manage the entire financial close process as well as consolidation, invoice-to-cash, and intercompany accounting. The Los Angeles–based company has 17 offices worldwide.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
BL vs NUTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $183.2M | $151.7M |
| Net Profit | $4.9M | $11.8M |
| Gross Margin | 75.2% | 30.4% |
| Operating Margin | 3.7% | 20.4% |
| Net Margin | 2.7% | 7.8% |
| Revenue YoY | 8.1% | -41.1% |
| Net Profit YoY | -91.3% | -80.8% |
| EPS (diluted) | $0.07 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $183.2M | $151.7M | ||
| Q3 25 | $178.3M | $267.8M | ||
| Q2 25 | $172.0M | $244.0M | ||
| Q1 25 | $166.9M | $211.8M | ||
| Q4 24 | $169.5M | $257.6M | ||
| Q3 24 | $165.9M | $78.8M | ||
| Q2 24 | $160.5M | $76.1M | ||
| Q1 24 | $157.5M | $67.5M |
| Q4 25 | $4.9M | $11.8M | ||
| Q3 25 | $5.3M | $55.4M | ||
| Q2 25 | $8.3M | $-17.7M | ||
| Q1 25 | $6.1M | $21.2M | ||
| Q4 24 | $56.4M | $61.6M | ||
| Q3 24 | $17.2M | $-8.8M | ||
| Q2 24 | $76.7M | $-364.0K | ||
| Q1 24 | $10.8M | $-364.0K |
| Q4 25 | 75.2% | 30.4% | ||
| Q3 25 | 75.1% | 57.8% | ||
| Q2 25 | 75.2% | 51.2% | ||
| Q1 25 | 75.5% | 55.9% | ||
| Q4 24 | 75.6% | 55.0% | ||
| Q3 24 | 75.2% | 27.8% | ||
| Q2 24 | 74.9% | 29.7% | ||
| Q1 24 | 75.2% | 15.1% |
| Q4 25 | 3.7% | 20.4% | ||
| Q3 25 | 4.3% | 48.7% | ||
| Q2 25 | 4.4% | 13.8% | ||
| Q1 25 | 2.1% | 38.1% | ||
| Q4 24 | 3.7% | 44.4% | ||
| Q3 24 | 5.0% | 12.3% | ||
| Q2 24 | 1.4% | 7.0% | ||
| Q1 24 | 1.1% | 2.1% |
| Q4 25 | 2.7% | 7.8% | ||
| Q3 25 | 3.0% | 20.7% | ||
| Q2 25 | 4.8% | -7.3% | ||
| Q1 25 | 3.6% | 10.0% | ||
| Q4 24 | 33.3% | 23.9% | ||
| Q3 24 | 10.4% | -11.2% | ||
| Q2 24 | 47.8% | -0.5% | ||
| Q1 24 | 6.9% | -0.5% |
| Q4 25 | $0.07 | $2.34 | ||
| Q3 25 | $0.09 | $7.76 | ||
| Q2 25 | $0.13 | $-2.95 | ||
| Q1 25 | $0.10 | $3.33 | ||
| Q4 24 | $0.79 | $11.56 | ||
| Q3 24 | $0.27 | $-1.72 | ||
| Q2 24 | $0.22 | $-0.07 | ||
| Q1 24 | $0.17 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $390.0M | $185.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $332.3M | $329.4M |
| Total Assets | $1.8B | $918.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $390.0M | $185.6M | ||
| Q3 25 | $419.9M | $166.0M | ||
| Q2 25 | $459.1M | $96.7M | ||
| Q1 25 | $479.5M | $84.7M | ||
| Q4 24 | $885.9M | $40.6M | ||
| Q3 24 | $725.3M | $46.9M | ||
| Q2 24 | $616.6M | $40.8M | ||
| Q1 24 | $331.4M | $30.0M |
| Q4 25 | $332.3M | $329.4M | ||
| Q3 25 | $328.3M | $317.2M | ||
| Q2 25 | $414.0M | $235.3M | ||
| Q1 25 | $417.9M | $176.9M | ||
| Q4 24 | $446.7M | $132.4M | ||
| Q3 24 | $367.9M | $60.4M | ||
| Q2 24 | $325.8M | $62.7M | ||
| Q1 24 | $279.8M | $63.0M |
| Q4 25 | $1.8B | $918.5M | ||
| Q3 25 | $1.7B | $964.5M | ||
| Q2 25 | $1.8B | $841.0M | ||
| Q1 25 | $1.8B | $761.9M | ||
| Q4 24 | $1.8B | $655.3M | ||
| Q3 24 | $1.7B | $438.5M | ||
| Q2 24 | $1.9B | $422.4M | ||
| Q1 24 | $2.1B | $404.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.7M | $70.4M |
| Free Cash FlowOCF − Capex | $26.1M | $69.0M |
| FCF MarginFCF / Revenue | 14.2% | 45.5% |
| Capex IntensityCapex / Revenue | 0.3% | 0.9% |
| Cash ConversionOCF / Net Profit | 5.46× | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | $161.5M | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.7M | $70.4M | ||
| Q3 25 | $63.8M | $99.5M | ||
| Q2 25 | $32.3M | $27.3M | ||
| Q1 25 | $46.7M | $51.0M | ||
| Q4 24 | $43.8M | $54.0K | ||
| Q3 24 | $55.9M | $6.8M | ||
| Q2 24 | $40.7M | $13.3M | ||
| Q1 24 | $50.4M | $3.1M |
| Q4 25 | $26.1M | $69.0M | ||
| Q3 25 | $63.3M | $99.2M | ||
| Q2 25 | $31.4M | $26.5M | ||
| Q1 25 | $40.8M | $50.9M | ||
| Q4 24 | $43.0M | $-341.0K | ||
| Q3 24 | $55.5M | $6.2M | ||
| Q2 24 | $40.0M | $12.7M | ||
| Q1 24 | $50.1M | $2.3M |
| Q4 25 | 14.2% | 45.5% | ||
| Q3 25 | 35.5% | 37.0% | ||
| Q2 25 | 18.2% | 10.9% | ||
| Q1 25 | 24.4% | 24.0% | ||
| Q4 24 | 25.4% | -0.1% | ||
| Q3 24 | 33.5% | 7.8% | ||
| Q2 24 | 24.9% | 16.7% | ||
| Q1 24 | 31.8% | 3.4% |
| Q4 25 | 0.3% | 0.9% | ||
| Q3 25 | 0.3% | 0.1% | ||
| Q2 25 | 0.6% | 0.3% | ||
| Q1 25 | 3.6% | 0.0% | ||
| Q4 24 | 0.4% | 0.2% | ||
| Q3 24 | 0.2% | 0.8% | ||
| Q2 24 | 0.4% | 0.7% | ||
| Q1 24 | 0.2% | 1.1% |
| Q4 25 | 5.46× | 5.95× | ||
| Q3 25 | 12.07× | 1.80× | ||
| Q2 25 | 3.90× | — | ||
| Q1 25 | 7.72× | 2.40× | ||
| Q4 24 | 0.78× | 0.00× | ||
| Q3 24 | 3.24× | — | ||
| Q2 24 | 0.53× | — | ||
| Q1 24 | 4.66× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BL
| Subscription And Circulation | $173.2M | 95% |
| Technology Service | $10.0M | 5% |
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
